IILGX
Price
$33.14
Change
-$0.09 (-0.27%)
Updated
Aug 31 closing price
Net Assets
2.54B
RWIEX
Price
$81.89
Change
-$0.42 (-0.51%)
Updated
Sep 1 closing price
Net Assets
155.99B
Interact to see
Advertisement

IILGX vs RWIEX

IILGX vs RWIEX Comparison Chart in %
View a ticker or compare two or three
VS
IILGX vs. RWIEX commentary
Sep 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IILGX is a StrongBuy and RWIEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIEX has more cash in the bank: 156B vs. IILGX (2.54B). IILGX (1.37) and RWIEX (1.32) have matching dividends . IILGX was incepted earlier than RWIEX: IILGX (29 years) vs RWIEX (24 years). RWIEX (0.76) is less costly to investors than IILGX (0.64). IILGX is a more actively managed with annual turnover of: 62.00 vs. RWIEX (44.00). RWIEX has a lower initial minimum investment than IILGX: RWIEX (250) vs IILGX (2000). RWIEX annual gain was more profitable for investors over the last year : 15.20 vs. IILGX (10.30). RWIEX return over 5 years is better than : 32.28 vs. IILGX (9.37).
IILGXRWIEXIILGX / RWIEX
Total Expense Ratio0.640.7684%
Annual Report Gross Expense Ratio0.640.7684%
Fund Existence29 years24 years-
Gain YTD13.18316.32881%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets2.54B156B2%
Annual Yield % from dividends1.371.32104%
Returns for 1 year10.3015.2068%
Returns for 3 years34.6450.4969%
Returns for 5 years9.3732.2829%
Returns for 10 years44.8793.6048%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NESYX67.24N/A
N/A
Natixis US Equity Opportunities Y
HIASX22.79N/A
N/A
Hartford Small Company HLS IA
HFYSX16.26N/A
N/A
Hartford Schroders Intl Multi-Cp Val R4
SNORX43.61N/A
N/A
Easterly Snow Long/Short Opportunity R6
FOTHX30.63N/A
N/A
Fidelity Advisor OTC I